VIROMED MEDICAL NA O.N. (VME) — Defensive Interval Ratio
VIROMED MEDICAL NA O.N. (VME) has a Defensive Interval Ratio of 197 days as of December 2025. Defensive assets of €1.12 Million (cash €-, short-term investments €4.51K, receivables €1.12 Million) cover 197 days of daily cash needs of €5.68K/day. See VIROMED MEDICAL NA O.N. (VME) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
VIROMED MEDICAL NA O.N. Defensive Interval Ratio (2024–2025)
This chart shows how VIROMED MEDICAL NA O.N.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 197 days, meaning defensive assets of €1.12 Million can fund 197 days of operations without new revenue. See VIROMED MEDICAL NA O.N. balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for VIROMED MEDICAL NA O.N. (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for VIROMED MEDICAL NA O.N. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see VME company net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 197 days | €1.12 Million | €5.68K/day | €- | €4.51K | ▲ +178 days |
| 2024 | 19 days | €148.12K | €7.82K/day | €- | €3.78K | — |